Home › NDC Lookup › RxCUI directory › RxCUI 2377369

Levamlodipine 2.5 MG Oral Tablet [Conjupri] — RxCUI 2377369

Name: Levamlodipine 2.5 MG Oral Tablet [Conjupri] (RxCUI 2377369)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic branded drug

RxCUI 2377369 Semantic branded drug · SBD ● Current RxNorm concept 2 FDA products 6 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2377369

Official nameLevamlodipine 2.5 MG Oral Tablet [Conjupri]

Concept typeSemantic branded drug (SBD)

RxNorm statusCurrent RxNorm concept

Also known asConjupri 2.5 MG Oral Tablet; Conjupri 2.5 MG (equivalent to levamlodipine maleate 3.2 MG) Oral Tablet

FDA products mapped2

Package NDCs mapped6

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

🕸️ Concept Web — How Levamlodipine 2.5 MG Oral Tablet [Conjupri] Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept Levamlodipine 2.5 MG Oral Tablet [Conjupri] RxCUI 2377369 Semantic branded drug · SBD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 1

The active substance itself — no strength, form, or brand attached yet.
- Levamlodipine 2376944 IN
Brand names 1

The same medicine's trade names. A brand name alone says nothing about strength or form.
- Conjupri 2377360 BN
Dose forms 9

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Levamlodipine Oral Tablet 2377358 SCDF
- Levamlodipine Oral Product 2377356 SCDG
- Levamlodipine Pill 2377357 SCDG
- Levamlodipine Oral Tablet [Conjupri] 2377362 SBDF
- Conjupri Oral Product 2377363 SBDG
- Conjupri Pill 2377364 SBDG
- Oral Tablet 317541 DF
- Oral Product 1151131 DFG
- +1 more in this family
Clinical & branded drugs 3

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- Levamlodipine 2.5 MG Oral Tablet 2377367 SCD
- Levamlodipine 2.5 MG 2377366 SCDC
- Levamlodipine 2.5 MG [Conjupri] 2377368 SBDC

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Levamlodipine 2.5 MG Oral Tablet SCD · 2377367
Levamlodipine 2.5 MG SCDC · 2377366
Levamlodipine Oral Tablet SCDF · 2377358
Levamlodipine Oral Product SCDG · 2377356
Levamlodipine Pill SCDG · 2377357

Brand-Name Concepts

Levamlodipine 2.5 MG [Conjupri] SBDC · 2377368
Levamlodipine Oral Tablet [Conjupri] SBDF · 2377362
Conjupri Oral Product SBDG · 2377363
Conjupri Pill SBDG · 2377364
Conjupri BN · 2377360

📦 FDA Products & Package NDCs

2 products · 6 package NDCs

6 package NDCs map to RxCUI 2377369 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
24075-0411-03	2.5 mg in 1 BOTTLE (24075-0411-3)	Conjupri	CSPC Ouyi Pharmaceutical Co. Ltd	2021-10-08
24075-0411-05	2.5 mg in 1 BOTTLE (24075-0411-5)	Conjupri	CSPC Ouyi Pharmaceutical Co. Ltd	2021-10-08
24075-0411-09	2.5 mg in 1 BOTTLE (24075-0411-9)	Conjupri	CSPC Ouyi Pharmaceutical Co. Ltd	2021-10-08
24075-0413-03	5 mg in 1 BOTTLE (24075-0413-3)	Conjupri	CSPC Ouyi Pharmaceutical Co. Ltd	2021-10-08
24075-0413-05	5 mg in 1 BOTTLE (24075-0413-5)	Conjupri	CSPC Ouyi Pharmaceutical Co. Ltd	2021-10-08
24075-0413-09	5 mg in 1 BOTTLE (24075-0413-9)	Conjupri	CSPC Ouyi Pharmaceutical Co. Ltd	2021-10-08

Observed labelers: CSPC Ouyi Pharmaceutical Co. Ltd (6) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.